Invo BioScience Net Profit Margin 2010-2024 | NAYA
Invo BioScience net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Invo BioScience Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-06-30 |
$0.01B |
$-0.01B |
-116.67% |
| 2024-03-31 |
$0.00B |
$-0.01B |
-175.00% |
| 2023-12-31 |
$0.00B |
$-0.01B |
-400.00% |
| 2023-09-30 |
$0.00B |
$-0.01B |
-900.00% |
| 2023-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2023-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2022-12-31 |
$0.00B |
$-0.01B |
inf% |
| 2022-09-30 |
$0.00B |
$-0.01B |
-300.00% |
| 2022-06-30 |
$0.00B |
$-0.01B |
-266.67% |
| 2022-03-31 |
$0.00B |
$-0.01B |
-233.33% |
| 2021-12-31 |
$0.00B |
$-0.01B |
-150.00% |
| 2021-09-30 |
$0.00B |
$-0.01B |
-1000.00% |
| 2021-06-30 |
$0.00B |
$-0.01B |
-1000.00% |
| 2021-03-31 |
$0.00B |
$-0.01B |
-900.00% |
| 2020-12-31 |
$0.00B |
$-0.01B |
inf% |
| 2020-09-30 |
$0.00B |
$-0.01B |
inf% |
| 2020-06-30 |
$0.00B |
$-0.00B |
inf% |
| 2020-03-31 |
$0.00B |
$-0.00B |
-300.00% |
| 2019-12-31 |
$0.00B |
$-0.00B |
-200.00% |
| 2019-09-30 |
$0.00B |
$-0.00B |
-200.00% |
| 2019-06-30 |
$0.00B |
$-0.00B |
-100.00% |
| 2019-03-31 |
$0.00B |
$-0.00B |
inf% |
| 2018-12-31 |
$0.00B |
$-0.00B |
inf% |
| 2018-09-30 |
$0.00B |
$-0.00B |
inf% |
| 2018-06-30 |
$0.00B |
$-0.00B |
inf% |
| 2018-03-31 |
$0.00B |
0 |
nan% |
| 2017-12-31 |
$0.00B |
0 |
nan% |
| 2017-09-30 |
$0.00B |
0 |
nan% |
| 2017-06-30 |
$0.00B |
0 |
nan% |
| 2017-03-31 |
$0.00B |
$-0.00B |
inf% |
| 2016-12-31 |
$0.00B |
$-0.00B |
inf% |
| 2016-06-30 |
$0.00B |
$-0.00B |
inf% |
| 2016-03-31 |
$0.00B |
$-0.00B |
inf% |
| 2015-09-30 |
$0.00B |
$-0.00B |
inf% |
| 2015-06-30 |
$0.00B |
$-0.00B |
inf% |
| 2015-03-31 |
$0.00B |
0 |
nan% |
| 2011-12-31 |
$0.00B |
0 |
nan% |
| 2011-09-30 |
$0.00B |
0 |
nan% |
| 2011-03-31 |
$0.00B |
0 |
nan% |
| 2010-12-31 |
$0.00B |
$0.00B |
inf% |
| 2010-06-30 |
$0.00B |
$-0.00B |
inf% |
| 2010-03-31 |
$0.00B |
$-0.00B |
inf% |
| 2009-12-31 |
$0.00B |
$-0.00B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.004B |
$0.003B |
|
INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. It engages in the development and manufacture of its lead product, INVOcell, a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. INVO Bioscience focuses on selling its product to IVF centers and physicians through distributors, as well as directly to physicians in Europe, Canada, Latin America, and the Middle East.
|
